“We may be rural hicks, but we’re not stupid,” said Kenneth Qualls, an Arkansas farmer who is a plaintiff in one of the lawsuits. “We know how to apply chemicals. They are going to blame it on the farmer to reduce their liability.”
Health risks are also a contentious topic. The industry says dicamba and 2,4-D are long established. But Charles Benbrook, a weed scientist partly funded by the organic industry, said, “For both dicamba and 2,4-D, the reproductive risks and birth defects” are “most worrisome.”
Dicamba is only one issue facing Monsanto. Public officials in Europe are divided about reauthorizing Roundup’s active ingredient, glyphosate. In the United States, Monsanto faces litigation over cancer claims related to glyphosate. That litigation has raised questions of ghostwriting of both journalism and academic papers by the company."
https://www.nytimes.com/2017/09/21/business/monsanto-dicamba-weed-killer.html
Health risks are also a contentious topic. The industry says dicamba and 2,4-D are long established. But Charles Benbrook, a weed scientist partly funded by the organic industry, said, “For both dicamba and 2,4-D, the reproductive risks and birth defects” are “most worrisome.”
Dicamba is only one issue facing Monsanto. Public officials in Europe are divided about reauthorizing Roundup’s active ingredient, glyphosate. In the United States, Monsanto faces litigation over cancer claims related to glyphosate. That litigation has raised questions of ghostwriting of both journalism and academic papers by the company."
https://www.nytimes.com/2017/09/21/business/monsanto-dicamba-weed-killer.html